Complex HBV populations with mutations in core promoter, C gene, and pre-S region are associated with development of cirrhosis in long-term renal transplant recipients
- 1 February 2002
- journal article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 35 (2) , 466-477
- https://doi.org/10.1053/jhep.2002.30698
Abstract
Long-term immunosuppressed renal transplant recipients with chronic hepatitis B virus (HBV) infection often develop liver cirrhosis (LC) and end-stage liver disease (ESLD). This study investigated accumulation and persistence of specific HBV mutants in relation to the clinical course in these patients (n = 38; mean follow-up, 3.5 years). HBV was analyzed longitudinally via length polymorphism of polymerase chain reaction (PCR) fragments (median, 6.5 serum samples per patient) as well as by cloning and partial sequencing of 346 full-length HBV genomes. Fourteen patients (group 1) developed LC or died from ESLD, whereas 24 patients (group 2) showed no evidence of LC during follow-up. Development of LC and ESLD was associated with persistence of HBV mutant populations characterized by deletions/insertions in core promoter plus deletions in the C gene and/or deletions in the pre-S region (86% of group 1 vs. 17% of group 2; P < .0001). HBV without these mutations or with core promoter mutations alone were predominantly found in group 2 (14% of group 1 vs. 75% of group 2). In patients infected with core promoter mutants, the additional appearance and persistence of deletions in the C gene and/or the pre-S region were accompanied or followed by development of LC and ESLD. The mutations were distributed on individual genomes in various combinations, leading to a high complexity of the virus population. In conclusion, these data suggest that accumulation and persistence of specific HBV populations characterized by mutations in 3 subgenomic regions play a role in pathogenesis of LC and ESLD in long-term renal transplant recipients.Keywords
Funding Information
- Bundesministerium für Bildung, Wissenschaft, Forschung und Technologie (01KI9560, 01KI9861, 01KI9555)
- European Commission (IC15-CT-98-0139)
- Humboldt-Universität zu Berlin
- Bundesministerium für Gesundheit and the Freie und Hansestadt Hamburg
This publication has 38 references indexed in Scilit:
- Repopulation of Mouse Liver With Human Hepatocytes And In Vivo Infection With Hepatitis B VirusHepatology, 2001
- A long-term hepatitis B viremia model generated by transplanting nontumorigenic immortalized human hepatocytes in Rag-2-deficient miceHepatology, 2000
- The Hepatitis B Virus-Trimera Mouse: A Model for Human Hbv Infection and Evaluation of Anti–Hbv Therapeutic AgentsHepatology, 1999
- A hepatitis B virus mutant with a new hepatocyte nuclear factor 1 binding site emerging in transplant-transmitted fulminant hepatitis BHepatology, 1997
- Accumulation and Persistence of Hepatitis B Virus Core Gene Deletion Mutants in Renal Transplant Patients Are Associated With End–Stage Liver DiseaseHepatology, 1996
- Hbsag Retention Sensitizes the Hepatocyte to Injury by Physiological Concentrations of Interferon–γHepatology, 1992
- MODULATION OF HEPATITIS B VIRAL ANTIGEN EXPRESSION BY IMMUNOSUPPRESSIVE DRUGS IN PRIMARY HEPATOCYTE CULTURETransplantation, 1992
- THE INCREASED RISK OF FATAL LIVER DISEASE IN RENAL TRANSPLANT PATIENTS WHO ARE HEPATITIS Be ANTIGEN AND/OR HBV DNA POSITIVETransplantation, 1991
- HEPATITIS B DISEASE IN DIALYSIS AND TRANSPLANT PATIENTS FURTHER EPIDEMIOLOGIC AND SEROLOGIC STUDIESTransplantation, 1987
- THE IMPACT OF RENAL TRANSPLANTATION ON THE COURSE OF HEPATITIS B LIVER DISEASETransplantation, 1985